SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-08-22 18:42
Tx date 2025-08-18
$ONC
Oncolytics Biotech Inc.
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$486,000
+450,000 vol
$1.08 each
5,200,000
Filed 2025-08-12 16:09
Tx date 2025-08-12
$ONC
Oncolytics Biotech Inc.
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,280
+23,500 vol
$0.86 each
73,900
Filed 2025-07-17 09:00
Tx date 2025-07-16
$ONC
Oncolytics Biotech Inc.
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$60,061
+50,400 vol
$1.19 each
50,400
Filed 2025-07-16 18:07
Tx date 2025-06-11
$ONC
Oncolytics Biotech Inc.
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-06-13 16:36
Tx date 2025-06-11
$ONC
Oncolytics Biotech Inc.
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+1 vol
1
Filed 2025-06-13 16:33
Tx date 2025-06-11
$ONC
Oncolytics Biotech Inc.
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,083,000
+1,900,000 vol
$0.57 each
4,750,000
Filed 2025-06-13 16:32
Tx date 2025-06-11
$ONC
Oncolytics Biotech Inc.
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,624,499
+2,850,000 vol
$0.57 each
2,850,000
Filed 2025-06-12 17:51
Tx date 2025-06-11
$ONC
Oncolytics Biotech Inc.
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2025-06-12 17:41
Tx date 2025-06-11
$ONC
Oncolytics Biotech Inc.
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report